TBCE and metabolic dysfunction-associated steatotic liver disease: Activating the nuclear receptor PPAR- δ facilitates M2 activation and improves obesity-induced glucose intolerance in mice, suggesting that this route may be used for NAFLD treatment despite the unknown function of M2 polarization of KCs in NAFLD [105,113].